In conclusion, this study has shown that eliminating the expression of RhoC by ribozyme technology in MDA-MB-231 breast cancer cells reduces their in vitro invasiveness compared with wild type MDA-MB-231 cells. This evidence concerns the gene RHOC and breast cancer.